Clinical effectiveness of statin therapy after ischemic stroke: Primary results from the statin therapeutic area of the patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study

Circulation

Volumn 132, Issue 15, 2015, Pages 1404-1413

  O'Brien, Emily C ^a   Greiner, Melissa A ^a   Xian, Ying ^a   Fonarow, Gregg C ^b   Olson, DaiWai M ^c   Schwamm, Lee H ^d   Bhatt, Deepak L ^g   Smith, Eric E ^e,f   Maisch, Lesley ^g   Hannah, Deidre ^g   Lindholm, Brianna ^g   Peterson, Eric D ^a   Pencina, Michael J ^a   Hernandez, Adrian F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALGARY   (Canada)

^g NONE

Author keywords

hydroxymethylglutaryl CoA reductase inhibitors; lipids; patient centered outcomes research; stroke

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HOME CARE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE PATIENT; TIME TO TREATMENT; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; DOSE RESPONSE; FOLLOW UP; MEDICAID; MEDICAL RECORD; MEDICARE; MULTICENTER STUDY; RECURRENT DISEASE; REGISTER; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICAID; MEDICAL RECORDS; MEDICARE; PATIENT DISCHARGE; PATIENT OUTCOME ASSESSMENT; PATIENT READMISSION; RECURRENCE; REGISTRIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84944145325     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.016183     Document Type: Article

References (33)

1. Lovett JK, Coull AJ, Rothwell PM, Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004 62 569 573
2. Collins R, Armitage J, Parish S, Sleight P, Peto R, Heart Protection Study Collaborative Group Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004 363 757 767. doi: 10.1016/S0140-6736(04)15690-0
3. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006 355 549 559. doi: 10.1056/NEJMoa061894
4. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011 42 227 276. doi: 10.1161/STR.0b013e3181f7d043
5. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 suppl 2 S1 S45. doi: 10.1161/01.cir.0000437738.63853.7a
6. Ovbiagele B, Schwamm LH, Smith EE, Hernandez AF, Olson DM, Pan W, Fonarow GC, Saver JL, Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke. Stroke 2010 41 1508 1513. doi: 10.1161/STROKEAHA.109.573618
7. Flint AC, Kamel H, Navi BB, Rao VA, Faigeles BS, Conell C, Klingman JG, Sidney S, Hills NK, Sorel M, Cullen SP, Johnston SC, Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke 2012 43 147 154. doi: 10.1161/STROKEAHA.111.627729
8. Hannah D, Lindholm B, Maisch L, Certain uncertainty: life after stroke from the patient's perspective. Circ Cardiovasc Qual Outcomes 2014 7 968 969. doi: 10.1161/CIRCOUTCOMES.114.001315
9. O'Brien EC, Xian Y, Fonarow GC, Olson DM, Schwamm LH, Hernandez AF, Clinical commentary on "Certain uncertainty: life after stroke from the patient's perspective." Circ Cardiovasc Qual Outcomes 2014 7 970. doi: 10.1161/CIRCOUTCOMES.114.001484
10. Xian Y, O'Brien EC, Fonarow GC, Olson DM, Schwamm LH, Hannah D, Lindholm B, Maisch L, Lytle BL, Greiner MA, Wu J, Peterson ED, Pencina MJ, Hernandez AF, Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: implementing the patient-driven research paradigm to aid decision making in stroke care. Am Heart J 2015 170 36 45.e11. doi: 10.1016/j.ahj.2015.04.008
11. The PCORI Methodology Report: Appendix A: Methodology Standards. Patient-Centered Outcomes Research Institute Web site. http://www.pcori.org/assets/2013/11/PCORI-Methodology-Report-Appendix-A.pdf. Updated November 2013. Accessed November 18, 2014
12. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, Ellrodt G, Cannon CP, Liang L, Peterson E, Labresh KA, Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation 2009 119 107 115. doi: 10.1161/CIRCULATIONAHA.108.783688
13. Fonarow GC, Reeves MJ, Zhao X, Olson DM, Smith EE, Saver JL, Schwamm LH, Get With the Guidelines-Stroke Steering Committee and Investigators Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation 2010 121 879 891. doi: 10.1161/CIRCULATIONAHA.109.892497
14. Reeves MJ, Fonarow GC, Smith EE, Pan W, Olson D, Hernandez AF, Peterson ED, Schwamm LH, Representativeness of the Get With The Guidelines-Stroke Registry: comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke. Stroke 2012 43 44 49. doi: 10.1161/STROKEAHA.111.626978
15. Hammill BG, Hernandez AF, Peterson ED, Fonarow GC, Schulman KA, Curtis LH, Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J 2009 157 995 1000. doi: 10.1016/j.ahj.2009.04.002
16. American Heart Association Data Viewer. American Heart Association Hospital Statistics. http://www.ahadataviewer.com/book-cd-products/AHA-Statistics/. Updated November 6, 2013. Accessed November 19, 2014
17. Harrell FE, Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis 2001 New York, NY Springer
18. Krumholz HM, Wang Y, Mattera JA, Wang Y, Han LF, Ingber MJ, Roman S, Normand SL, An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation 2006 113 1693 1701. doi: 10.1161/CIRCULATIONAHA.105.611194
19. Wahl PM, Rodgers K, Schneeweiss S, Gage BF, Butler J, Wilmer C, Nash M, Esper G, Gitlin N, Osborn N, Short LJ, Bohn RL, Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf 2010 19 596 603. doi: 10.1002/pds.1924
20. Healthcare Cost and Utilization Project (HCUP). Clinical Classifications Software (CCS) for ICD-9-CM. http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Updated November 17, 2014. Accessed November 19, 2014
21. Curtis LH, Hammill BG, Eisenstein EL, Kramer JM, Anstrom KJ, Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care 2007 45 suppl 2 S103 S107. doi: 10.1097/MLR.0b013e31806518ac
22. Austin PC, Grootendorst P, Anderson GM, A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med 2007 26 734 753. doi: 10.1002/sim.2580
23. Quinn TJ, Dawson J, Lees JS, Chang TP, Walters MR, Lees KR, GAIN and VISTA Investigators Time spent at home poststroke: "home-time" a meaningful and robust outcome measure for stroke trials. Stroke 2008 39 231 233. doi: 10.1161/STROKEAHA.107.493320
24. Slutsky JR, Clancy CM, Patient-centered comparative effectiveness research: essential for high-quality care. Arch Intern Med 2010 170 403 404. doi: 10.1001/archinternmed.2010.5
25. Ní Chróinín D, Callaly EL, Duggan J, Merwick Á Hannon N, Sheehan Ó Marnane M, Horgan G, Williams EB, Harris D, Kyne L, McCormack PM, Moroney J, Grant T, Williams D, Daly L, Kelly PJ, Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study. Stroke 2011 42 1021 1029. doi: 10.1161/STROKEAHA.110.596734
26. Fareed M, Suri K, Qureshi AI, Recruitment of ischemic stroke patients in clinical trials in general practice and implications for generalizability of results. J Vasc Interv Neurol 2012 5 27 32
27. Heiat A, Gross CP, Krumholz HM, Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002 162 1682 1688
28. Chen J, Ye X, Yan T, Zhang C, Yang XP, Cui X, Cui Y, Zacharek A, Roberts C, Liu X, Dai X, Lu M, Chopp M, Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke 2011 42 3551 3558. doi: 10.1161/STROKEAHA.111.627174
29. Selim MH, Molina CA, High-dose statin for every stroke: the good, the bad, and the unknown. Stroke 2012 43 1996 1997. doi: 10.1161/STROKEAHA.111.648832
30. Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE, Donner A, Mamdani M, Douketis JD, Arima H, Chalmers J, MacMahon S, Tirschwell DL, Psaty BM, Bushnell CD, Aguilar MI, Capampangan DJ, Werring DJ, De Rango P, Viswanathan A, Danchin N, Cheng CL, Yang YH, Verdel BM, Lai MS, Kennedy J, Uchiyama S, Yamaguchi T, Ikeda Y, Mrkobrada M, Statins and intracerebral hemorrhage: collaborative systematic review and meta-Analysis. Circulation 2011 124 2233 2242. doi: 10.1161/CIRCULATIONAHA.111.055269
31. McKinney JS, Kostis WJ, Statin therapy and the risk of intracerebral hemorrhage: A meta-Analysis of 31 randomized controlled trials. Stroke 2012 43 2149 2156. doi: 10.1161/STROKEAHA.112.655894
32. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED, Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001 286 708 713
33. Shrank WH, Patrick AR, Brookhart MA, Healthy user and related biases in observational studies of preventive interventions: A primer for physicians. J Gen Intern Med 2011 26 546 550. doi: 10.1007/s11606-010-1609-1